Guardant Health, Inc. ( GH) - Key Metrics
GH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.54 | -$0.91 | -$0.44 | -$0.53 |
| 2026Q1 | $2.30 | -$0.85 | -$0.50 | -$0.54 |
| 2025Q4 | $2.19 | -$1 | -$0.20 | -$0.42 |
| 2025Q3 | $2.12 | -$0.74 | -$0.28 | -$0.37 |
| 2025Q2 | $1.87 | -$0.80 | -$0.49 | -$0.53 |
GH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -41.68 |
| 2026Q1 | 0% | -27.17 |
| 2025Q4 | 0% | -25.54 |
| 2025Q3 | 0% | -21.11 |
| 2025Q2 | 0% | -16.26 |
GH
Price: $162.59
52 week price:
Payout Ratio Range:
Earnings Per Share: -3.59 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 409714
Market Capitalization: 23.9 billion